TRAVERE THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 15925000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b239222b-4b3f-412b-b4ba-4eb8e1839a13
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-21-000008Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b239222b-4b3f-412b-b4ba-4eb8e1839a13
History
- no predecessors — first report